Moderna signs agreement with Gavi to supply COVID-19 vaccine
Biotech ties up deal three days after World Health Organization issued an emergency use listing for the mRNA vaccine
Moderna has agreed a deal with Gavi, the Vaccine Alliance to supply up to 500 million doses of its COVID-19 vaccine to low- and middle-income countries, the biotech said on Monday.
Under the terms of the supply agreement made with Gavi, the Vaccine Alliance — an international organisation created to improve access to new and underused vaccines for children living in the world's poorest countries — on behalf of COVAX, Moderna will deliver an initial 34 million doses in the fourth quarter of 2021.
Through this advanced purchase agreement (APA), Gavi also has the option to buy 466 million additional doses in 2022, and options to potentially access doses of variant-adapted vaccine in the future. All doses are offered at Moderna’s lowest tiered price in line with its global access commitments , the biotech said.
Initial supply of the mRNA vaccine covers the 92 Gavi COVAX Advance Market Commitment (AMC) low- and middle-income countries, with the potential to allocate and supply to self-financing participants in the future.
Last week, the Moderna vaccine received WHO Emergency Use Listing, making it eligible to be supplied to COVAX Facility participants.
COVAX is a global initiative co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, to ensure equitable access to COVID-19 vaccines for all countries, regardless of income levels.
Moderna’s vaccine is part of the COVAX R&D portfolio. In January 2020, COVAX co-lead CEPI provided initial investment in Moderna’s COVID-19 vaccine programme to support production of the first clinical trial materials.
Following on from the negotiation and signing of the APA between Gavi and Moderna, a long-term agreement will be signed between UNICEF and Moderna to enable the logistics of procurement and delivery of these doses to Gavi COVAX AMC participants.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance